Monday, April 22, 2024
    HomeHyderabadUSFDA and DCA join forces for strategic initiatives in State

    USFDA and DCA join forces for strategic initiatives in State

    Related stories

    Madhavi Latha, BJP MP candidate from Hyderabad, addresses complaint against her

    BJP candidate K Madhavilatha, who ran for the Hyderabad...

    Man assaults bus driver for stopping to eat

    In Vikarabad, a man named Nawaz attacked RTC bus...

    MLC Kavitha’s bail petition to be heard at Rouse Avenue Court

    MLC Kavitha, who is currently in Tihar Jail in...

    The US Food and Drug Administration (USFDA) has partnered with the Drugs Control Administration (DCA) in Telangana for future initiatives. The two organizations held their first annual regulatory forum on January 31 in Hyderabad. The DCA in Telangana is working to combat the production and sale of counterfeit drugs, as well as other illegal activities that pose a serious risk to public health.

    As the regulatory authority in Telangana, the DCA has implemented various measures to ensure the safety of pharmaceuticals produced in the state. These include risk-based inspections and sampling, strict testing guidelines for raw materials used in cough syrups, the creation of a vigilance cell to detect illegal activities, unannounced inspections of chemical factories, and stringent review of licenses for manufacturers.

    - Advertisement -
    Also read:  Chandrababu Naidu distributes B forms to TDP Lok Sabha and Assembly candidates

    During the forum, USFDA officials discussed the possibility of DCA inspectors from Telangana participating as observers in USFDA-led inspections. The purpose of the annual regulatory forum is to identify best practices and opportunities for collaboration between the two organizations. It also allows for an exchange of information about their respective operations and practices.

    In November 2023, a team of USFDA officials visited the DCA office in Hyderabad and proposed the establishment of a “USFDA-Telangana DCA Regulatory Forum” for future collaboration. This is because Telangana has more than 214 USFDA registered manufacturing sites that produce and export medicines to the USA.

    - Advertisement -

    The first annual regulatory forum took place on January 31, 2024, in Hyderabad. USFDA officials, including Dr. Sarah McMullen, Dr. Phil Nguyen, Yvins Dezan, Guerlain Ulysse, Dr. Sudheendra Kulkarni, and Dhruv Shav, participated in the forum alongside DCA Telangana.

    Also read:  Health department to fill over 16,000 job vacancies

    During the forum, the DCA presented an overview of its regulatory program and current initiatives, while USFDA officials discussed their recent initiatives and inspection trends in India. They also gave presentations on their medical products program, manufacturing facility oversight, and regulatory actions, as well as their approaches to the pharmaceutical quality system and risk-based inspections.

    - Advertisement -

    Follow us


    Contribute News

    You can contribute an article to Telangana Tribune by dropping a mail at

    Latest stories


    Please enter your comment!
    Please enter your name here